Venus Remedies Limited — Others, 22-08-2025: Shareholders meeting

Venus Remedies held its Annual General Meeting to adopt the audited annual standalone and consolidated financial statements. Shareholders approved re-appointing several key directors, including the Managing Director, Deputy Managing Director, and Executive Directors, for five-year terms. An Independent Director was also re-appointed for a second five-year term. Additionally, shareholders ratified the cost auditor's remuneration at Rs. 1.10 lakh per annum and appointed a new secretarial auditor. The Chairman provided an overview of the company's performance and future outlook, followed by an interactive Q&A session with investors.